世界のエピジェネティクス医薬品・診断技術市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Epigenetics Drugs and Diagnostic Technologies Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2229 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、エピジェネティクス医薬品・診断技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HDAC阻害剤、DNMT阻害剤）、用途別市場規模（ノンコーディングRNA、マイクロRNA、ヒストン修飾、DNAメチル化）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・エピジェネティクス医薬品・診断技術の市場動向 ・企業の競争状況、市場シェア ・エピジェネティクス医薬品・診断技術の種類別市場規模（HDAC阻害剤、DNMT阻害剤） ・エピジェネティクス医薬品・診断技術の用途別市場規模（ノンコーディングRNA、マイクロRNA、ヒストン修飾、DNAメチル化） ・エピジェネティクス医薬品・診断技術の北米市場規模2016-2027（アメリカ、カナダ） ・エピジェネティクス医薬品・診断技術のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・エピジェネティクス医薬品・診断技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エピジェネティクス医薬品・診断技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・エピジェネティクス医薬品・診断技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Varlix Plc、Topotarget、Syndax Pharmaceuticals、Spectrum Pharmaceuticals、Promega、Novartis、Oncolys BioPharma、MDxHealth、Merck、Illumina、Epizyme、Forum Pharmaceuticals、EpiGentek、Chroma Therapeutics、Celleron Therapeutics、CellCentric、Astex Pharmaceuticals、Acetylon Pharmaceuticals、4SC AG、Eisai、Pharmacyclics） ・結論

Market Analysis and Insights: Global Epigenetics Drugs and Diagnostic Technologies Market
The global Epigenetics Drugs and Diagnostic Technologies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epigenetics Drugs and Diagnostic Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epigenetics Drugs and Diagnostic Technologies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epigenetics Drugs and Diagnostic Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epigenetics Drugs and Diagnostic Technologies market.

Global Epigenetics Drugs and Diagnostic Technologies Scope and Market Size
Epigenetics Drugs and Diagnostic Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epigenetics Drugs and Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
HDAC inhibitors
DNMT inhibitors

Segment by Application
Non coding RNA’s
Micro RNA’s
Histone modifications
DNA methylation

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Varlix Plc
Topotarget
Syndax Pharmaceuticals
Spectrum Pharmaceuticals
Promega
Novartis
Oncolys BioPharma
MDxHealth
Merck
Spectrum Pharmaceuticals
Promega
Forum Pharmaceuticals
EpiGentek
Chroma Therapeutics
Celleron Therapeutics
CellCentric
Astex Pharmaceuticals
Acetylon Pharmaceuticals
4SC AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HDAC inhibitors
1.2.3 DNMT inhibitors
1.3 Market by Application
1.3.1 Global Epigenetics Drugs and Diagnostic Technologies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Non coding RNA’s
1.3.3 Micro RNA’s
1.3.4 Histone modifications
1.3.5 DNA methylation
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epigenetics Drugs and Diagnostic Technologies Market Perspective (2016-2027)
2.2 Epigenetics Drugs and Diagnostic Technologies Growth Trends by Regions
2.2.1 Epigenetics Drugs and Diagnostic Technologies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epigenetics Drugs and Diagnostic Technologies Historic Market Share by Regions (2016-2021)
2.2.3 Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Regions (2022-2027)
2.3 Epigenetics Drugs and Diagnostic Technologies Industry Dynamic
2.3.1 Epigenetics Drugs and Diagnostic Technologies Market Trends
2.3.2 Epigenetics Drugs and Diagnostic Technologies Market Drivers
2.3.3 Epigenetics Drugs and Diagnostic Technologies Market Challenges
2.3.4 Epigenetics Drugs and Diagnostic Technologies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epigenetics Drugs and Diagnostic Technologies Players by Revenue
3.1.1 Global Top Epigenetics Drugs and Diagnostic Technologies Players by Revenue (2016-2021)
3.1.2 Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Players (2016-2021)
3.2 Global Epigenetics Drugs and Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epigenetics Drugs and Diagnostic Technologies Revenue
3.4 Global Epigenetics Drugs and Diagnostic Technologies Market Concentration Ratio
3.4.1 Global Epigenetics Drugs and Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Drugs and Diagnostic Technologies Revenue in 2020
3.5 Epigenetics Drugs and Diagnostic Technologies Key Players Head office and Area Served
3.6 Key Players Epigenetics Drugs and Diagnostic Technologies Product Solution and Service
3.7 Date of Enter into Epigenetics Drugs and Diagnostic Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epigenetics Drugs and Diagnostic Technologies Breakdown Data by Type
4.1 Global Epigenetics Drugs and Diagnostic Technologies Historic Market Size by Type (2016-2021)
4.2 Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Type (2022-2027)

5 Epigenetics Drugs and Diagnostic Technologies Breakdown Data by Application
5.1 Global Epigenetics Drugs and Diagnostic Technologies Historic Market Size by Application (2016-2021)
5.2 Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epigenetics Drugs and Diagnostic Technologies Market Size (2016-2027)
6.2 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Type
6.2.1 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021)
6.2.2 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2022-2027)
6.2.3 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2027)
6.3 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Application
6.3.1 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2021)
6.3.2 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2022-2027)
6.3.3 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2027)
6.4 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country
6.4.1 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2016-2021)
6.4.2 North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Epigenetics Drugs and Diagnostic Technologies Market Size (2016-2027)
7.2 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Type
7.2.1 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021)
7.2.2 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2022-2027)
7.2.3 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2027)
7.3 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Application
7.3.1 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2021)
7.3.2 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2022-2027)
7.3.3 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2027)
7.4 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country
7.4.1 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2016-2021)
7.4.2 Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size (2016-2027)
8.2 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Type
8.2.1 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2027)
8.3 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Application
8.3.1 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2027)
8.4 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Region
8.4.1 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size (2016-2027)
9.2 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Type
9.2.1 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021)
9.2.2 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2022-2027)
9.2.3 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2027)
9.3 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Application
9.3.1 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2021)
9.3.2 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2022-2027)
9.3.3 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2027)
9.4 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country
9.4.1 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2016-2021)
9.4.2 Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size (2016-2027)
10.2 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Type
10.2.1 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2027)
10.3 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Application
10.3.1 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2027)
10.4 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Country
10.4.1 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Varlix Plc
11.1.1 Varlix Plc Company Details
11.1.2 Varlix Plc Business Overview
11.1.3 Varlix Plc Epigenetics Drugs and Diagnostic Technologies Introduction
11.1.4 Varlix Plc Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.1.5 Varlix Plc Recent Development
11.2 Topotarget
11.2.1 Topotarget Company Details
11.2.2 Topotarget Business Overview
11.2.3 Topotarget Epigenetics Drugs and Diagnostic Technologies Introduction
11.2.4 Topotarget Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.2.5 Topotarget Recent Development
11.3 Syndax Pharmaceuticals
11.3.1 Syndax Pharmaceuticals Company Details
11.3.2 Syndax Pharmaceuticals Business Overview
11.3.3 Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Introduction
11.3.4 Syndax Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.3.5 Syndax Pharmaceuticals Recent Development
11.4 Spectrum Pharmaceuticals
11.4.1 Spectrum Pharmaceuticals Company Details
11.4.2 Spectrum Pharmaceuticals Business Overview
11.4.3 Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Introduction
11.4.4 Spectrum Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.4.5 Spectrum Pharmaceuticals Recent Development
11.5 Promega
11.5.1 Promega Company Details
11.5.2 Promega Business Overview
11.5.3 Promega Epigenetics Drugs and Diagnostic Technologies Introduction
11.5.4 Promega Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.5.5 Promega Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Epigenetics Drugs and Diagnostic Technologies Introduction
11.6.4 Novartis Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Oncolys BioPharma
11.7.1 Oncolys BioPharma Company Details
11.7.2 Oncolys BioPharma Business Overview
11.7.3 Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Introduction
11.7.4 Oncolys BioPharma Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.7.5 Oncolys BioPharma Recent Development
11.8 MDxHealth
11.8.1 MDxHealth Company Details
11.8.2 MDxHealth Business Overview
11.8.3 MDxHealth Epigenetics Drugs and Diagnostic Technologies Introduction
11.8.4 MDxHealth Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.8.5 MDxHealth Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Epigenetics Drugs and Diagnostic Technologies Introduction
11.9.4 Merck Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.9.5 Merck Recent Development
11.10 Illumina
11.10.1 Illumina Company Details
11.10.2 Illumina Business Overview
11.10.3 Illumina Epigenetics Drugs and Diagnostic Technologies Introduction
11.10.4 Illumina Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.10.5 Illumina Recent Development
11.11 Epizyme
11.11.1 Epizyme Company Details
11.11.2 Epizyme Business Overview
11.11.3 Epizyme Epigenetics Drugs and Diagnostic Technologies Introduction
11.11.4 Epizyme Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.11.5 Epizyme Recent Development
11.12 Forum Pharmaceuticals
11.12.1 Forum Pharmaceuticals Company Details
11.12.2 Forum Pharmaceuticals Business Overview
11.12.3 Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Introduction
11.12.4 Forum Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.12.5 Forum Pharmaceuticals Recent Development
11.13 EpiGentek
11.13.1 EpiGentek Company Details
11.13.2 EpiGentek Business Overview
11.13.3 EpiGentek Epigenetics Drugs and Diagnostic Technologies Introduction
11.13.4 EpiGentek Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.13.5 EpiGentek Recent Development
11.14 Chroma Therapeutics
11.14.1 Chroma Therapeutics Company Details
11.14.2 Chroma Therapeutics Business Overview
11.14.3 Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Introduction
11.14.4 Chroma Therapeutics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.14.5 Chroma Therapeutics Recent Development
11.15 Celleron Therapeutics
11.15.1 Celleron Therapeutics Company Details
11.15.2 Celleron Therapeutics Business Overview
11.15.3 Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Introduction
11.15.4 Celleron Therapeutics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.15.5 Celleron Therapeutics Recent Development
11.16 CellCentric
11.16.1 CellCentric Company Details
11.16.2 CellCentric Business Overview
11.16.3 CellCentric Epigenetics Drugs and Diagnostic Technologies Introduction
11.16.4 CellCentric Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.16.5 CellCentric Recent Development
11.17 Astex Pharmaceuticals
11.17.1 Astex Pharmaceuticals Company Details
11.17.2 Astex Pharmaceuticals Business Overview
11.17.3 Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Introduction
11.17.4 Astex Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.17.5 Astex Pharmaceuticals Recent Development
11.18 Acetylon Pharmaceuticals
11.18.1 Acetylon Pharmaceuticals Company Details
11.18.2 Acetylon Pharmaceuticals Business Overview
11.18.3 Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Introduction
11.18.4 Acetylon Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.18.5 Acetylon Pharmaceuticals Recent Development
11.18 4SC AG
.1 4SC AG Company Details
.2 4SC AG Business Overview
.3 4SC AG Epigenetics Drugs and Diagnostic Technologies Introduction
.4 4SC AG Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
.5 4SC AG Recent Development
11.20 Eisai
11.20.1 Eisai Company Details
11.20.2 Eisai Business Overview
11.20.3 Eisai Epigenetics Drugs and Diagnostic Technologies Introduction
11.20.4 Eisai Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.20.5 Eisai Recent Development
11.21 Pharmacyclics
11.21.1 Pharmacyclics Company Details
11.21.2 Pharmacyclics Business Overview
11.21.3 Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Introduction
11.21.4 Pharmacyclics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
11.21.5 Pharmacyclics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HDAC inhibitors
Table 3. Key Players of DNMT inhibitors
Table 4. Global Epigenetics Drugs and Diagnostic Technologies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Epigenetics Drugs and Diagnostic Technologies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Epigenetics Drugs and Diagnostic Technologies Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Regions (2016-2021)
Table 8. Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Regions (2022-2027)
Table 10. Epigenetics Drugs and Diagnostic Technologies Market Trends
Table 11. Epigenetics Drugs and Diagnostic Technologies Market Drivers
Table 12. Epigenetics Drugs and Diagnostic Technologies Market Challenges
Table 13. Epigenetics Drugs and Diagnostic Technologies Market Restraints
Table 14. Global Epigenetics Drugs and Diagnostic Technologies Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Players (2016-2021)
Table 16. Global Top Epigenetics Drugs and Diagnostic Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenetics Drugs and Diagnostic Technologies as of 2020)
Table 17. Ranking of Global Top Epigenetics Drugs and Diagnostic Technologies Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Epigenetics Drugs and Diagnostic Technologies Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Epigenetics Drugs and Diagnostic Technologies Product Solution and Service
Table 21. Date of Enter into Epigenetics Drugs and Diagnostic Technologies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Type (2016-2021)
Table 25. Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Epigenetics Drugs and Diagnostic Technologies Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Application (2016-2021)
Table 29. Global Epigenetics Drugs and Diagnostic Technologies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size by Country (2022-2027) & (US$ Million)
Table 61. Varlix Plc Company Details
Table 62. Varlix Plc Business Overview
Table 63. Varlix Plc Epigenetics Drugs and Diagnostic Technologies Product
Table 64. Varlix Plc Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 65. Varlix Plc Recent Development
Table 66. Topotarget Company Details
Table 67. Topotarget Business Overview
Table 68. Topotarget Epigenetics Drugs and Diagnostic Technologies Product
Table 69. Topotarget Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 70. Topotarget Recent Development
Table 71. Syndax Pharmaceuticals Company Details
Table 72. Syndax Pharmaceuticals Business Overview
Table 73. Syndax Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
Table 74. Syndax Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 75. Syndax Pharmaceuticals Recent Development
Table 76. Spectrum Pharmaceuticals Company Details
Table 77. Spectrum Pharmaceuticals Business Overview
Table 78. Spectrum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
Table 79. Spectrum Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 80. Spectrum Pharmaceuticals Recent Development
Table 81. Promega Company Details
Table 82. Promega Business Overview
Table 83. Promega Epigenetics Drugs and Diagnostic Technologies Product
Table 84. Promega Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 85. Promega Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Epigenetics Drugs and Diagnostic Technologies Product
Table 89. Novartis Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Oncolys BioPharma Company Details
Table 92. Oncolys BioPharma Business Overview
Table 93. Oncolys BioPharma Epigenetics Drugs and Diagnostic Technologies Product
Table 94. Oncolys BioPharma Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 95. Oncolys BioPharma Recent Development
Table 96. MDxHealth Company Details
Table 97. MDxHealth Business Overview
Table 98. MDxHealth Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 99. MDxHealth Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Epigenetics Drugs and Diagnostic Technologies Product
Table 103. Merck Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 104. Merck Recent Development
Table 105. Illumina Company Details
Table 106. Illumina Business Overview
Table 107. Illumina Epigenetics Drugs and Diagnostic Technologies Product
Table 108. Illumina Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 109. Illumina Recent Development
Table 110. Epizyme Company Details
Table 111. Epizyme Business Overview
Table 112. Epizyme Epigenetics Drugs and Diagnostic Technologies Product
Table 113. Epizyme Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 114. Epizyme Recent Development
Table 115. Forum Pharmaceuticals Company Details
Table 116. Forum Pharmaceuticals Business Overview
Table 117. Forum Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
Table 118. Forum Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 119. Forum Pharmaceuticals Recent Development
Table 120. EpiGentek Company Details
Table 121. EpiGentek Business Overview
Table 122. EpiGentek Epigenetics Drugs and Diagnostic Technologies Product
Table 123. EpiGentek Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 124. EpiGentek Recent Development
Table 125. Chroma Therapeutics Company Details
Table 126. Chroma Therapeutics Business Overview
Table 127. Chroma Therapeutics Epigenetics Drugs and Diagnostic Technologies Product
Table 128. Chroma Therapeutics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 129. Chroma Therapeutics Recent Development
Table 130. Celleron Therapeutics Company Details
Table 131. Celleron Therapeutics Business Overview
Table 132. Celleron Therapeutics Epigenetics Drugs and Diagnostic Technologies Product
Table 133. Celleron Therapeutics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 134. Celleron Therapeutics Recent Development
Table 135. CellCentric Company Details
Table 136. CellCentric Business Overview
Table 137. CellCentric Epigenetics Drugs and Diagnostic Technologies Product
Table 138. CellCentric Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 139. CellCentric Recent Development
Table 140. Astex Pharmaceuticals Company Details
Table 141. Astex Pharmaceuticals Business Overview
Table 142. Astex Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
Table 143. Astex Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 144. Astex Pharmaceuticals Recent Development
Table 145. Acetylon Pharmaceuticals Company Details
Table 146. Acetylon Pharmaceuticals Business Overview
Table 147. Acetylon Pharmaceuticals Epigenetics Drugs and Diagnostic Technologies Product
Table 148. Acetylon Pharmaceuticals Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 149. Acetylon Pharmaceuticals Recent Development
Table 150. 4SC AG Company Details
Table 151. 4SC AG Business Overview
Table 152. 4SC AG Epigenetics Drugs and Diagnostic Technologies Product
Table 153. 4SC AG Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 154. 4SC AG Recent Development
Table 155. Eisai Company Details
Table 156. Eisai Business Overview
Table 157. Eisai Epigenetics Drugs and Diagnostic Technologies Product
Table 158. Eisai Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 159. Eisai Recent Development
Table 160. Pharmacyclics Company Details
Table 161. Pharmacyclics Business Overview
Table 162. Pharmacyclics Epigenetics Drugs and Diagnostic Technologies Product
Table 163. Pharmacyclics Revenue in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021) & (US$ Million)
Table 164. Pharmacyclics Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Type: 2020 VS 2027
Figure 2. HDAC inhibitors Features
Figure 3. DNMT inhibitors Features
Figure 4. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Application: 2020 VS 2027
Figure 5. Non coding RNA’s Case Studies
Figure 6. Micro RNA’s Case Studies
Figure 7. Histone modifications Case Studies
Figure 8. DNA methylation Case Studies
Figure 9. Epigenetics Drugs and Diagnostic Technologies Report Years Considered
Figure 10. Global Epigenetics Drugs and Diagnostic Technologies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Epigenetics Drugs and Diagnostic Technologies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Regions: 2020 VS 2027
Figure 13. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Regions (2022-2027)
Figure 14. Global Epigenetics Drugs and Diagnostic Technologies Market Share by Players in 2020
Figure 15. Global Top Epigenetics Drugs and Diagnostic Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenetics Drugs and Diagnostic Technologies as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Epigenetics Drugs and Diagnostic Technologies Revenue in 2020
Figure 17. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Type (2016-2021)
Figure 18. Global Epigenetics Drugs and Diagnostic Technologies Revenue Market Share by Type (2022-2027)
Figure 19. North America Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Epigenetics Drugs and Diagnostic Technologies Market Share by Type (2016-2027)
Figure 21. North America Epigenetics Drugs and Diagnostic Technologies Market Share by Application (2016-2027)
Figure 22. North America Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2016-2027)
Figure 23. United States Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Epigenetics Drugs and Diagnostic Technologies Market Share by Type (2016-2027)
Figure 27. Europe Epigenetics Drugs and Diagnostic Technologies Market Share by Application (2016-2027)
Figure 28. Europe Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2016-2027)
Figure 29. Germany Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Epigenetics Drugs and Diagnostic Technologies Market Share by Region (2016-2027)
Figure 39. China Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Epigenetics Drugs and Diagnostic Technologies Market Share by Type (2016-2027)
Figure 47. Latin America Epigenetics Drugs and Diagnostic Technologies Market Share by Application (2016-2027)
Figure 48. Latin America Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2016-2027)
Figure 49. Mexico Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Epigenetics Drugs and Diagnostic Technologies Market Share by Country (2016-2027)
Figure 55. Turkey Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Epigenetics Drugs and Diagnostic Technologies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Varlix Plc Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 59. Topotarget Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 60. Syndax Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 61. Spectrum Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 62. Promega Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 64. Oncolys BioPharma Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 65. MDxHealth Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 67. Illumina Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 68. Epizyme Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 69. Forum Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 70. EpiGentek Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 71. Chroma Therapeutics Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 72. Celleron Therapeutics Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 73. CellCentric Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 74. Astex Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 75. Acetylon Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 76. 4SC AG Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 77. Eisai Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 78. Pharmacyclics Revenue Growth Rate in Epigenetics Drugs and Diagnostic Technologies Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

---